01 1Nantong Jinghua Pharmaceutical
01 1PRIMIDONE
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2020-08-04
Pay. Date : 2020-04-02
DMF Number : 21602
Submission : 2008-05-08
Status : Active
Type : II
20
Nantong Jinghua Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is PRIMIDONE, with a corresponding US DMF Number 21602.
Remarkably, this DMF maintains an Active status since its submission on May 08, 2008, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 04, 2020, and payment made on April 02, 2020, indicating their dedication to facilitating drug approvals, Categorized as Type II
